|
|
|
|
| LEADER |
02530nam a2200661 4500 |
| 001 |
ocn884646529 |
| 003 |
OCoLC |
| 005 |
20170124071139.7 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
140726s2014 gw o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d N$T
|d E7B
|d DEBSZ
|d OCLCQ
|d OCLCF
|d RECBK
|d DG1
|d DEBBG
|d OCLCQ
|d EBLCP
|d EBLB
|d AZK
|d GrThAP
|
| 019 |
|
|
|a 961585847
|a 962644829
|
| 020 |
|
|
|a 9783527665211
|q (electronic bk.)
|
| 020 |
|
|
|a 3527665218
|q (electronic bk.)
|
| 020 |
|
|
|a 9783527665242
|q (electronic bk.)
|
| 020 |
|
|
|a 3527665242
|q (electronic bk.)
|
| 020 |
|
|
|z 9783527333653
|
| 020 |
|
|
|z 3527333657
|
| 020 |
|
|
|z 9783527665235
|
| 020 |
|
|
|z 9783527665228
|
| 029 |
1 |
|
|a DEBBG
|b BV043396993
|
| 029 |
1 |
|
|a DEBSZ
|b 414127714
|
| 029 |
1 |
|
|a DEBBG
|b BV043891685
|
| 035 |
|
|
|a (OCoLC)884646529
|z (OCoLC)961585847
|z (OCoLC)962644829
|
| 050 |
|
4 |
|a RS431.P38
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.19
|a 615/.19
|2 22
|
| 049 |
|
|
|a MAIN
|
| 100 |
1 |
|
|a Ghosh, Arun K.
|
| 245 |
1 |
0 |
|a Structure-based design of drugs and other bioactive molecules :
|b tools and strategies /
|c Arun K. Ghosh and Sandra Gemma.
|
| 264 |
|
1 |
|a Weinheim :
|b Wiley-VCH,
|c 2014.
|
| 300 |
|
|
|a 1 online resource (476 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 504 |
|
|
|a Includes bibliographical references at the end of each chapters and index.
|
| 650 |
|
0 |
|a Drug development.
|
| 650 |
|
0 |
|a Bioactive compounds.
|
| 650 |
|
0 |
|a Biopolymers.
|
| 650 |
|
0 |
|a Ligand binding (Biochemistry)
|
| 650 |
|
0 |
|a Protease inhibitors.
|
| 650 |
|
0 |
|a Drugs
|x Structure-activity relationships.
|
| 650 |
|
4 |
|a Drugs
|x Design.
|
| 650 |
|
4 |
|a Drugs.
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Bioactive compounds.
|2 fast
|0 (OCoLC)fst00831933
|
| 650 |
|
7 |
|a Biopolymers.
|2 fast
|0 (OCoLC)fst00832670
|
| 650 |
|
7 |
|a Drug development.
|2 fast
|0 (OCoLC)fst00898670
|
| 650 |
|
7 |
|a Drugs
|x Structure-activity relationships.
|2 fast
|0 (OCoLC)fst00898929
|
| 650 |
|
7 |
|a Ligand binding (Biochemistry)
|2 fast
|0 (OCoLC)fst00998460
|
| 650 |
|
7 |
|a Protease inhibitors.
|2 fast
|0 (OCoLC)fst01079610
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Gemma, Sandra.
|
| 776 |
0 |
8 |
|i Print version:
|a Ghosh, Arun K.
|t Structure-based Design of Drugs and Other Bioactive Molecules.
|d Hoboken : Wiley, 2014
|z 9783527333653
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9783527665211
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
